May 25, 2022CorporateTerumo Blood and Cell Technologies Inaugurates Second Manufacturing Facility in Colorado
May 17, 2022CorporateTerumo Pharmaceutical Solutions Offers Pre-Fillable Syringe Solutions for Demanding Low Dose Applications Such as Ophthalmic
May 16, 2022CorporateTerumo Announces Change in Indication for Dexcom G6 CGM System in Japan Adjunctive use of Blood Glucose Meter Principally Not Required
May 16, 2022 Q&A regarding Financial Results for the FYE 3/2022 May 13, 2022 Audio webcast regarding Financial Results for FYE 3/2022 May 12, 2022 Presentation regarding Financial Results for FYE 3/2022 February 14, 2022 Q&A regarding Financial Results for the Third Quarter of FYE 3/2022 February 10, 2022 Audio webcast regarding Financial Results for the Third Quarter of FYE 3/2022 February 09, 2022 Presentation regarding Financial Results for the Third Quarter of FYE 3/2022 December 20, 2021 Audio webcast regarding 5-Year Growth Strategy with a 10-Year Vision December 20, 2021 Q&A regarding 5-Year Growth Strategy with a 10-Year Vision December 20, 2021 Presentation regarding 5-Year Growth Strategy with a 10-Year Vision Pagination Previous page ‹ Current page1 Next page ›